Dexcom Sues InSpark Technologies Over Glucose Patents, Claims Non-infringement

Dexcom has filed a suit against InSpark Technologies, claiming it did not infringe on three patents related to glucose-monitoring technology.

InSpark Technologies holds the three patents in dispute that concern the methods for evaluating and monitoring glucose.

Dexcom is requesting a declaratory judgment of non-infringement for ’703 patent, ’985 patent and ’425 patent concerning its Dexcom Clarity software. — José Vasquez